SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-038870
Filing Date
2021-03-19
Accepted
2021-03-19 12:55:52
Documents
3
Period of Report
2021-03-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2110350d1_8k.htm 8-K 16114
2 EXHIBIT 99.1 tm2110350d1_ex99-1.htm EX-99.1 10940
3 GRAPHIC tm2110350d1_ex99-1img001.jpg GRAPHIC 3499
  Complete submission text file 0001104659-21-038870.txt   33261
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15070 | Film No.: 21757326
SIC: 2834 Pharmaceutical Preparations